EMILIO
BOUZA SANTIAGO
Investigador fins a 2020
Hospital Universitario de Valme
Sevilla, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario de Valme (7)
2020
-
Recommendations for the diagnosis and treatment of clostridioides difficile infection: An official clinical practice guideline of the spanish society of chemotherapy (SEQ), spanish society of internal medicine (SEMI) and the working group of postoperative infection of the spanish society of anesthesia and reanimation (SEDAR)
Revista Espanola de Quimioterapia, Vol. 33, Núm. 2, pp. 151-175
2017
-
Is routine ophthalmoscopy really necessary in candidemic patients?
PLoS ONE, Vol. 12, Núm. 10
-
No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins
Diagnostic Microbiology and Infectious Disease, Vol. 88, Núm. 2, pp. 141-144
2012
-
The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?
Clinical Microbiology and Infection, Vol. 18, Núm. 7
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277
2007
-
Update on vascular catheter-related infections
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 37-46
2003
-
Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults
Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 5, pp. 826-836